Abstract
Brain ischemia resulting from multiple disease states including cardiac arrest, stroke and traumatic brain injury, is a leading cause of death and disability. Despite significant resources dedicated to developing pharmacological interventions, few effective therapeutic options are currently available. The basic consequence of cerebral ischemia, characterized by energy failure and subsequent brain metabolic abnormalities, enables the protective effects by pharmacological manipulation of brain metabolism. We present here the important roles of brain glycogen metabolism and propose inhibition of glycogenolysis as a therapeutic approach to cerebral ischemia.
Keywords: Brain glycogen, cerebral ischemia, glycogenolysis, inhibitors, Brain ischemia, traumatic brain injury, brain glycogen metabolism, Brain, Neurons, glycogen synthase, Astrocytes, neurotransmitters, glycogen phosphorylase, phosphorylase kinase, glucose-6-phosphate, hypoglycemia, oxidative phosphorylation, glutamate mediated excitotox-icity, Glycogen Storage, methinionine sulfoximine, glucose-depleted brain tissue, glutathione system, Glutathione disulfide, Amelioration of Lactic Acidosis, glycolytic pathway, glycolytic substrate, Mitochondria, reactive oxygen species, Maslinic Acid, CP-316819, Magnesium Sulfate, N-methyl-D-aspartate, Uridine diphosphate glucose, uridine triphos-phate, glucose-1-phosphate uridyltrans-ferase, electroencephalogram
Mini-Reviews in Medicinal Chemistry
Title: Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Volume: 10 Issue: 12
Author(s): L. Xu and H. Sun
Affiliation:
Keywords: Brain glycogen, cerebral ischemia, glycogenolysis, inhibitors, Brain ischemia, traumatic brain injury, brain glycogen metabolism, Brain, Neurons, glycogen synthase, Astrocytes, neurotransmitters, glycogen phosphorylase, phosphorylase kinase, glucose-6-phosphate, hypoglycemia, oxidative phosphorylation, glutamate mediated excitotox-icity, Glycogen Storage, methinionine sulfoximine, glucose-depleted brain tissue, glutathione system, Glutathione disulfide, Amelioration of Lactic Acidosis, glycolytic pathway, glycolytic substrate, Mitochondria, reactive oxygen species, Maslinic Acid, CP-316819, Magnesium Sulfate, N-methyl-D-aspartate, Uridine diphosphate glucose, uridine triphos-phate, glucose-1-phosphate uridyltrans-ferase, electroencephalogram
Abstract: Brain ischemia resulting from multiple disease states including cardiac arrest, stroke and traumatic brain injury, is a leading cause of death and disability. Despite significant resources dedicated to developing pharmacological interventions, few effective therapeutic options are currently available. The basic consequence of cerebral ischemia, characterized by energy failure and subsequent brain metabolic abnormalities, enables the protective effects by pharmacological manipulation of brain metabolism. We present here the important roles of brain glycogen metabolism and propose inhibition of glycogenolysis as a therapeutic approach to cerebral ischemia.
Export Options
About this article
Cite this article as:
Xu L. and Sun H., Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia, Mini-Reviews in Medicinal Chemistry 2010; 10 (12) . https://dx.doi.org/10.2174/1389557511009011188
DOI https://dx.doi.org/10.2174/1389557511009011188 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Crystallography of Membrane Proteins, Major Targets in Drug Design
Mini-Reviews in Medicinal Chemistry From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Innovative Formulations for the Controlled and Site-specific Delivery of Antiinflammatory Drugs
Current Pharmaceutical Design Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Progress in Drug Treatment of Cerebral Edema
Mini-Reviews in Medicinal Chemistry Adult Neurogenesis: Can Analysis of Cell Cycle Proteins Move Us “Beyond BrdU”?
Current Pharmaceutical Biotechnology Natural Endoperoxides as Drug Lead Compounds
Current Medicinal Chemistry Hepatocyte Growth Factor and Insulin-like Growth Factor-1 based Cellular Therapies for Oxidative Stress Injury
Current Stem Cell Research & Therapy Pharmacokinetics of Inter-Alpha Inhibitor Proteins and Effects on Hemostasis After Hypoxic-Ischemic Brain Injury in Neonatal Rats
Current Pharmaceutical Design Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
Current Medicinal Chemistry Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases
Current Drug Targets - CNS & Neurological Disorders Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies
Current Medicinal Chemistry Phytotherapeutic and Natural Compound Applications for Age-Related, Inflammatory and Serious Eye Ailments
Current Molecular Pharmacology Expression and Function of Cytokines and Chemokines in Neuropsychiatric Related Systemic Lupus Erythematosus
Current Rheumatology Reviews Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases
Current Nanoscience Therapy Against Reperfusion-induced Microvascular Injury
Current Pharmaceutical Design A Case of Neurosarcoidosis Mimicking Brain Tumor
Current Medical Imaging Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment
Current Medicinal Chemistry Screening for Inhibitors of Microglia to Reduce Neuroinflammation
CNS & Neurological Disorders - Drug Targets Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design